Rheumatoid arthritis (RA) is a disease of the joints that causes decreased quality of life.
Mesenchymal stromal cells (MSCs) have immunosuppressive properties, with possible use …

Objective We investigated the effects of single or repetitive intra-articular injections of
synovial mesenchymal stem cells (MSCs) on a rat osteoarthritis (OA) model, and elucidated …

The therapeutic and immunomodulatory potential of mesenchymal stem cells (MSCs) in
rheumatoid arthritis (RA) has attracted considerable scientific attention in recent decades …

Objective: In recent times, it has been recognized that mesenchymal stem cells (MSCs)
possess the capability to address osteoarthritis (OA). The objective of this research was to …

Background Recently, cell-based tissue engineering approaches using mesenchymal stem
cells (MSCs) have been used to treat osteoarthritis (OA). However, the efficacy of human …

Mesenchymalstem cell (MSC)-based therapy is being increasingly explored in preclinical
and clinical studies as a regenerative method for treating osteoarthritis (OA). However, the …

Background As current therapies for canine osteoarthritis (OA) provide mainly symptomatic
improvement and fail to address the complex pathology of the disease, mesenchymal stem …

Osteoarthritis (OA) is a degenerative joint disease caused by chronic inflammation that
damages articular cartilage. At present, the treatment of OA includes drug therapy to relieve …

Osteoarthritis (OA) is a leading cause of chronic pain and disability, for which there is no
cure. Mesenchymal stromal cells (MSCs) have been used in clinical trials for treating OA due …

Introduction Chronic inflammation causes articular bone and cartilage degeneration in
people with rheumatoid arthritis (RA). Despite recent advancements in the management of …